Chargement en cours...
Direct renin inhibition in chronic kidney disease
For approximately 6 years, the only commercially available direct renin inhibitor, aliskiren, which inhibits the renin-angiotensin-aldosterone system at the initial rate limiting step, has been marketed for the treatment of hypertension. Concurrently, much attention has been given to the possibility...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Science Inc
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3791981/ https://ncbi.nlm.nih.gov/pubmed/23278708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12072 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|